EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications

10.1186/s13045-019-0814-6

Saved in:

Bibliographic Details
Main Authors:	Li, B., Chng, W.-J.
Other Authors:	MEDICINE
Format:	Review
Published:	BioMed Central Ltd. 2021
Subjects:	B cell EBV EZH2 EZH2 inhibitor Lymphoid malignancies Lymphoma T cell
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/210718
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-210718
record_format	dspace
spelling	sg-nus-scholar.10635-2107182024-11-09T14:53:21Z EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications Li, B. Chng, W.-J. MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE B cell EBV EZH2 EZH2 inhibitor Lymphoid malignancies Lymphoma T cell 10.1186/s13045-019-0814-6 Journal of Hematology and Oncology 12 1 118 2021-12-16T07:46:04Z 2021-12-16T07:46:04Z 2019 Review Li, B., Chng, W.-J. (2019). EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications. Journal of Hematology and Oncology 12 (1) : 118. ScholarBank@NUS Repository. https://doi.org/10.1186/s13045-019-0814-6 17568722 https://scholarbank.nus.edu.sg/handle/10635/210718 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ BioMed Central Ltd. Scopus OA2019
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	B cell EBV EZH2 EZH2 inhibitor Lymphoid malignancies Lymphoma T cell
spellingShingle	B cell EBV EZH2 EZH2 inhibitor Lymphoid malignancies Lymphoma T cell Li, B. Chng, W.-J. EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
description	10.1186/s13045-019-0814-6
author2	MEDICINE
author_facet	MEDICINE Li, B. Chng, W.-J.
format	Review
author	Li, B. Chng, W.-J.
author_sort	Li, B.
title	EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
title_short	EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
title_full	EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
title_fullStr	EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
title_full_unstemmed	EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
title_sort	ezh2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
publisher	BioMed Central Ltd.
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/210718
_version_	1821199730857738240

EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications

Similar Items